At the epicenter of the Ebola outbreak, many face another danger as well
outbreak will spread. It has killed nearly 1,100 in the Democratic Republic of Congo. At the epicenter of the outbreak, many face another danger, other than the disease.
There have been major advances in the treatment of Ebola since the last deadly outbreak in 2014. Now patients are put in plastic cubes which provides a protective barrier between doctor and patient. There is also a new Ebola vaccine which should be good news for the Democratic Republic of Congo in its fight against its deadliest outbreak to date.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Congo officials say 2nd Ebola case confirmed in city of GomaThe latest Ebola outbreak to hit Democratic Republic of Congo has killed more than 1,700 people since August last year.
Read more »
Congo officials say 2nd Ebola case confirmed in city of GomaThere appeared to be no link between the new case and the previous one in the city.
Read more »
U.S. Ebola patients mark 5 years since recovery amid outbreak in CongoAs a new Ebola outbreak rages in Congo, some of the first Ebola virus patients to be successfully treated in the U.S. during the deadliest recorded outbreak five years ago are reuniting with their doctors.
Read more »
First two Ebola cases confirmed in Congo's South Kivu: officialsA woman and her child were the first two cases confirmed with Ebola in Congo&03...
Read more »
Ebola-ravaged Congo now hit with 87,000 suspected measles cases, officials sayA measles epidemic has been declared in the Democratic Republic of the Congo, a country already struggling to contain the world's second-largest and second-deadliest Ebola outbreak.
Read more »
Researchers publish dexamethasone findingsResearchers on Monday published preprint research that led to the U.K.'s decision to approve the steroid dexamethasone as a treatment for some severely ill COVID-19 patients. The U.K. had first shared preliminary findings from the trial last week. The study is in preprint form and has not been peer-reviewed, which is considered the gold standard in clinical research. However, during the coronavirus pandemic, preprints have become a popular way to more quickly release scientific data about the virus and potential treatments. The U.K.'s randomized study assessed the use of dexamethasone in 2,104 patients. An additional 4,321 patients received the standard of care. About 21.6% of the patients who received the steroid died, compared with 24.6% of the patients who had the standard of care. Of the patients who received the steroid who were on mechanical ventilators, 29.0% died, compared with 40.7% of patients on ventilators receiving the standard of care. And among patients receiving oxygen and dexamethasone, 21.5% died, as compared to 25.0% of patients who received oxygen and the standard of care. The drug did not benefit COVID-19 patients who were not receiving oxygen or ventilation in the study. The mean age of the clinical study's participants was about 66 years old; about two-thirds of patients in the trial were men; and about half of the patients who received dexamethasone had a pre-existing condition, such as diabetes or heart disease. "Dexamethasone provides an effective treatment for the sickest patients with [COVID-19] and, given its low cost, well-understood safety profile, and widespread availability, is one that can be used worldwide," the University of Oxford researchers concluded.
Read more »